Olmesartan vs losartan efficacy
Pro Research Analysisby 
Searched over 200M research papers
Comparative Efficacy of Olmesartan vs Losartan in Hypertension
Blood Pressure Reduction: Olmesartan vs Losartan
Multiple studies have directly compared the efficacy of olmesartan and losartan in lowering blood pressure in patients with hypertension. Across several randomized, double-blind trials, olmesartan consistently produced a greater reduction in both diastolic and systolic blood pressure compared to losartan at their respective starting doses. For example, olmesartan reduced sitting cuff diastolic blood pressure (DBP) by 11.5–13.5 mm Hg, which was significantly greater than the 8.2 mm Hg reduction seen with losartan. Similarly, olmesartan achieved a greater reduction in 24-hour ambulatory DBP and systolic blood pressure (SBP) than losartan, indicating a more sustained antihypertensive effect throughout the day Mujeeb2015Oparil2001Zhu2006+5 MORE.
Response Rates and Blood Pressure Goal Achievement
Studies also found that a higher percentage of patients achieved target blood pressure goals (<140/90 mm Hg) with olmesartan compared to losartan. This was true for both patients new to antihypertensive therapy and those previously treated, with olmesartan showing a significantly greater proportion of patients reaching the desired blood pressure targets Zhu2006Punzi2012Chen2007.
Duration and Consistency of Effect
Olmesartan demonstrated a more durable antihypertensive effect over a 24-hour period, as shown by higher trough-to-peak ratios in both systolic and diastolic blood pressure compared to losartan. This suggests that olmesartan maintains its blood pressure-lowering effect more consistently throughout the dosing interval Zhu2006Kalikar2017Stumpe2002.
Safety and Tolerability
Both olmesartan and losartan were well tolerated, with similar rates of mild and transient adverse events reported in clinical trials. No significant differences in safety profiles were observed between the two drugs, and both were considered safe for use in patients with mild to moderate hypertension Dong-Hai2012Zhu2006Punzi2012+2 MORE.
Meta-Analyses and Broader Comparisons
While individual studies often found olmesartan to be more effective, a meta-analysis of randomized controlled trials concluded that there was no statistically significant difference in overall efficacy or safety between olmesartan and losartan. This suggests that while olmesartan may offer some advantages in certain measures, both drugs are generally effective and safe options for hypertension management Dong-Hai2012Kalikar2017.
Conclusion
In summary, olmesartan generally provides greater and more sustained reductions in blood pressure compared to losartan, with a higher likelihood of achieving target blood pressure goals. Both medications are well tolerated with similar safety profiles. However, some meta-analyses suggest that the overall differences in efficacy and safety may not be statistically significant, indicating that both drugs remain viable choices for treating hypertension.
Sources and full results
Most relevant research papers on this topic